• A <em>GDF2</em> missense mutation potentially involved in the pathogenesis of hereditary hemorrhagic telangiectasia: a case report
• A 37-Year-Old Man with Familial Hereditary Hemorrhagic Telangiectasia and Pulmonary Arteriovenous Malformations Presenting with Seizures and a Diagnosis of Brain Abscesses
• A Case of Paradoxical Cerebral Embolism Due to Pulmonary Arteriovenous Fistula Mimicking Vertebral Artery Dissection With Wallenberg Syndrome
• A case report of isolated right ventricular noncompaction with mutation of ACVRL1: a new cause of noncompaction of ventricular myocardium?
• A case report on uneventful anticoagulation and persistence of Type 1 Respiratory Failure post severe COVID-19 infection in a patient of Osler-Weber-Rendu syndrome
• A rare homozygous missense GDF2 (BMP9) mutation causing PAH in siblings: Does BMP10 status contribute?
• ABNORMAL RETINAL REFLECTIVITY TO SHORT-WAVELENGTH LIGHT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA
• Adaptive optics microperimetry and OCT images show preserved function and recovery of cone visibility in macular telangiectasia type 2 retinal lesions
• ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation
• An <em>in vitro</em> study on the effect of bevacizumab on endothelial cell proliferation and VEGF concentration level in patients with hereditary hemorrhagic telangiectasia
• An evaluation of the severity and progression of epistaxis in hereditary hemorrhagic telangiectasia 1 versus hereditary hemorrhagic telangiectasia 2
• Anesthetic management of a patient with Osler-Weber-Rendu syndrome with multiple pulmonary arteriovenous malformations and pheochromocytoma for femoral artificial bone replacement: a case report
• ANG2 Blockade Diminishes Proangiogenic Cerebrovascular Defects Associated With Models of Hereditary Hemorrhagic Telangiectasia
• Antiplatelet and anticoagulant therapies in hereditary hemorrhagic telangiectasia: A large French cohort study (RETROPLACOTEL)
• Antithrombotic therapy for atrial fibrillation in hereditary hemorrhagic telangiectasia
• Bioinformatic analysis of pathogenic missense mutations of activin receptor like kinase 1 ectodomain
• BMP10 functions independently from BMP9 for the development of a proper arteriovenous network
• Brain Abscess and Stroke in Children and Adults With Hereditary Hemorrhagic Telangiectasia: Analysis of a Large National Claims Database
• Brain Abscess as a Complication of Hereditary Hemorrhagic Telangiectasia: A Case Report
• Can aura migraine be elicited by isolated pulmonary arteriovenous fistula?-A case report
• Case Report: Clinical characteristics and genetic analysis of two patients with hereditary hemorrhagic telangiectasia
• CHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA
• Clinical Guidelines for Diagnosis and Management of Juvenile Polyposis Syndrome in Children and Adults-Secondary Publication
• Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief report
• Comparison of Transthoracic Contrast Echocardiography with High-Resolution Chest CT after Embolization of Pulmonary Arteriovenous Malformation
• Computational and Experimental Analyses for Pathogenicity Prediction of <em>ACVRL1</em> Missense Variants in Hereditary Hemorrhagic Telangiectasia
• CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY
• CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 6-The MacTel Research Group
• CORRELATION OF STRUCTURAL AND FUNCTIONAL OUTCOME MEASURES IN A PHASE ONE TRIAL OF CILIARY NEUROTROPHIC FACTOR IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA
• DARK ADAPTATION IN MACULAR TELANGIECTASIA TYPE 2
• Dysfunction of endothelial BMP-9 signaling in pulmonary vascular disease
• EFFECT OF DARK ADAPTATION AND BLEACHING ON BLUE LIGHT REFLECTANCE IMAGING IN MACULAR TELANGIECTASIA TYPE 2
• Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial
• Efficacy and Safety of Tacrolimus as Treatment for Bleeding Caused by Hereditary Hemorrhagic Telangiectasia: An Open-Label, Pilot Study
• Efficacy and Safety of Venous Sac Embolization With or Without Feeding Artery Embolization Versus Feeding Artery Embolization Alone in the Management of Pulmonary Arteriovenous Malformations: A Systematic Review and Meta-analysis
• Enhanced responses to angiogenic cues underlie the pathogenesis of hereditary hemorrhagic telangiectasia 2
• Establishment of a human induced pluripotent stem cell line, KMUGMCi001-A, from a patient bearing a heterozygous c.772 + 3_772 + 4dup mutation in the ACVRL1 gene leading Telangiectasia, hereditary hemorrhagic, type 2 (HHT2)
• Evolution of Intrahepatic Shunts in a Patient With Hereditary Hemorrhagic Telangiectasia
• Frequency of epistaxis and telangiectasia in patients with hereditary hemorrhagic telangiectasia (HHT) in comparison with the general population: Curaçao diagnostic criteria revisited
• Functional characteristics of macular telangiectasia type 2
• Functional Relevance of Hyper-Reflectivity in Macular Telangiectasia Type 2
• FUNDUS-WIDE SUBRETINAL AND PIGMENT EPITHELIAL ABNORMALITIES IN MACULAR TELANGIECTASIA TYPE 2
• Gastric angiodysplasia in a hereditary hemorrhagic telangiectasia type 2 patient
• Generation of a Syngeneic Heterozygous <em>ACVRL1^(wt/mut)</em> Knockout iPS Cell Line for the In Vitro Study of HHT2-Associated Angiogenesis
• Hepatic angiodynamic profile in paediatric patients with hereditary haemorrhagic telangiectasia type 1 and type 2
• Human <em>SMAD4</em> Genomic Variants Identified in Individuals with Heritable and Early-Onset Thoracic Aortic Disease
• Identifying racial disparities in hereditary hemorrhagic telangiectasia
• Impact of SARS-CoV-2 infection in patients with hereditary hemorrhagic telangiectasia: epidemiological and clinical data from the comprehensive Italian retrospective multicenter study
• Interaction Between ALK1 Signaling and Connexin40 in the Development of Arteriovenous Malformations
• Intravitreal anti-VEGF treatment for subretinal neovascularisation secondary to type 2 idiopathic juxtafoveolar telangiectasia
• Isolated Pulmonary Arteriovenous Malformations Associated With BMPR2 Pathogenic Variants
• Late Hemorrhage Following Laparoscopic Cholecystectomy
• Localized conditional induction of brain arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia
• Long-term use of somatostatin analogs for chronic gastrointestinal bleeding in hereditary hemorrhagic telangiectasia
• Longitudinal Assessment of Curaçao Criteria in Children with Hereditary Hemorrhagic Telangiectasia
• LONGITUDINAL CORRELATION OF ELLIPSOID ZONE LOSS AND FUNCTIONAL LOSS IN MACULAR TELANGIECTASIA TYPE 2
• MACULAR PIGMENT DISTRIBUTION RESPONSES TO HIGH-DOSE ZEAXANTHIN SUPPLEMENTATION IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2
• MACULAR TELANGIECTASIA TYPE 2: Quantitative Analysis of a Novel Phenotype and Implications for the Pathobiology of the Disease
• Macular telangiectasia type 2: The international MacTel project
• Management outcomes of peripontine arteriovenous malformation patients presenting with trigeminal neuralgia
• Mechanical thrombectomy for acute paradoxical cerebral embolism due to pulmonary arteriovenous malformation: A case report and review of literature
• Morphological characteristics in macular telangiectasia type 2
• Multidisciplinary coordinated care of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)
• Multiple brain arteriovenous malformations: systematic review and individual patient data meta-analysis
• Natural history and effect of therapeutic interventions on subretinal fluid causing foveal detachment in macular telangiectasia type 2
• Not Your Typical Nosebleed: A Case Report and Personal Account of a Patient With Osler-Weber-Rendu Syndrome
• Novel human pathological mutations. Gene symbol: ACVRL1. Disease: haemorrhagic telangiectasia 2
• Obstetrical and neonatal complications in hereditary haemorrhagic telangiectasia: A retrospective study
• Osler-Weber-Rendu syndrome: A case report on a rare vascular malformation presented with lower gastrointestinal bleeding
• OTULIN allies with LUBAC to govern angiogenesis by editing ALK1 linear polyubiquitin
• Pediatric pulmonary arterial hypertension due to a novel homozygous GDF2 missense variant affecting BMP9 processing and activity
• Perioperative Complications and Long-Term Follow-Up of Liver Transplantation in Hemorrhagic Hereditary Telangiectasia: Report of Three Cases and Systematic Review
• PI3K (Phosphatidylinositol 3-Kinase) Activation and Endothelial Cell Proliferation in Patients with Hemorrhagic Hereditary Telangiectasia Type 1
• Postoperative Pain Following Coblation of Sinonasal Hereditary Hemorrhagic Telangiectasias
• Prevalence and Risk Factors for Bleeding in Hereditary Hemorrhagic Telangiectasia: A National Inpatient Sample Study
• Pulmonary arterio-venous malformations in a patient with a novel mutation in exon 10 of the ACVRL1 gene
• Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia
• Recurrent Vein of Galen Aneurysmal Malformation as a Presentation of Hereditary Hemorrhagic Telangiectasia
• Reduced mural cell coverage and impaired vessel integrity after angiogenic stimulation in the Alk1-deficient brain
• Resection of Frontal Arteriovenous Malformation, Residual Pericallosal Arteriovenous Fistula, and Micro-Arteriovenous Malformation in a Child With Hereditary Hemorrhagic Telangiectasia: 2-Dimensional Operative Video
• Retinal ganglion cells thinning in eyes with nonproliferative idiopathic macular telangiectasia type 2A
• Ruptured bilateral brain arteriovenous malformations in a young woman with early pregnancy: a case report
• Safety, tolerability, and effectiveness of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia
• Schizencephaly in Hereditary Hemorrhagic Telangiectasia
• SCOTOMA CHARACTERISTICS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 7-The MacTel Research Group
• Seven cases of hereditary haemorrhagic telangiectasia-like hepatic vascular abnormalities associated with <em>EPHB4</em> pathogenic variants
• SEX STEROIDS AND MACULAR TELANGIECTASIA TYPE 2
• Sex-biased TGFβ signaling in pulmonary arterial hypertension
• Significance of transesophageal contrast echocardiography with the agitated saline test for diagnosing pulmonary arteriovenous malformations
• Spontaneous hemothorax in pregnant patient with pulmonary arteriovenous malformation
• Surgiflo® hemostatic matrix versus NasoPore® nasal packing following postassium titanyl phosphate laser surgery for hereditary hemorrhagic telangiectasia: A randomized controlled trial
• Swept-source OCT angiography of macular telangiectasia type 2
• Targeted Diode Laser Therapy for Oral and Perioral Capillary-Venous Malformation in Pediatric Patients: A Prospective Study
• The Importance of a Multidisciplinary Approach in a Patient with Long-term Multisystemic Manifestations of Unrecognized Hereditary Hemorrhagic Telangiectasia
• The Shunt of It
• The Use of Beta-Blockers in Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic Review
• Therapeutic approaches for macular telangiectasia type 2: status quo and perspectives
• Update on pulmonary arteriovenous malformations
• VASCULAR DISTORTION AND DRAGGING RELATED TO APPARENT TISSUE CONTRACTION IN MACULAR TELANGIECTASIS TYPE 2
• VISUAL FUNCTION CORRELATES OF FOVEAL SLOPE CHANGES ON OPTICAL COHERENCE TOMOGRAPHY IN MACULAR TELANGIECTASIA TYPE 2